LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 37

Search options

  1. Article ; Online: Inclusion Across the Lifespan in Cardiovascular Trials-A Long Road Ahead.

    DeJong, Colette / Covinsky, Kenneth

    JAMA internal medicine

    2020  Volume 180, Issue 11, Page(s) 1533–1534

    MeSH term(s) Cardiovascular Diseases/therapy ; Humans ; Longevity
    Language English
    Publishing date 2020-09-07
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2020.2735
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Shining a Light on Industry Payments to Health Care Professionals Who Are Not Physicians.

    DeJong, Colette / Steinbrook, Robert

    JAMA internal medicine

    2019  Volume 179, Issue 10, Page(s) 1432–1433

    Language English
    Publishing date 2019-06-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2019.1367
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018.

    Inoue, Kosuke / DeJong, Colette / Nangaku, Masaomi

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

    2021  Volume 27, Issue 5, Page(s) 503–504

    MeSH term(s) Adult ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Angiotensins ; Humans ; United States/epidemiology
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Angiotensins
    Language English
    Publishing date 2021-05-02
    Publishing country United States
    Document type Letter
    ZDB-ID 1473503-9
    ISSN 1530-891X
    ISSN 1530-891X
    DOI 10.1016/j.eprac.2020.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Continuing Problems With Financial Conflicts of Interest and Clinical Practice Guidelines.

    DeJong, Colette / Steinbrook, Robert

    JAMA internal medicine

    2018  Volume 178, Issue 12, Page(s) 1715

    MeSH term(s) Conflict of Interest ; Disclosure ; Financial Support ; Gastroenterology ; Industry
    Language English
    Publishing date 2018-11-01
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2018.4974
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.

    Kazi, Dhruv S / DeJong, Colette / Chen, Randi / Wadhera, Rishi K / Tseng, Chien-Wen

    Journal of the American College of Cardiology

    2023  Volume 81, Issue 21, Page(s) 2103–2111

    Abstract: Background: High out-of-pocket costs can impede access to guideline-directed cardiovascular drugs. The 2022 Inflation Reduction Act (IRA) will eliminate catastrophic coinsurance and cap annual out-of-pocket costs for Medicare Part D patients by 2025.: ...

    Abstract Background: High out-of-pocket costs can impede access to guideline-directed cardiovascular drugs. The 2022 Inflation Reduction Act (IRA) will eliminate catastrophic coinsurance and cap annual out-of-pocket costs for Medicare Part D patients by 2025.
    Objectives: This study sought to estimate the IRA's impact on out-of-pocket costs for Part D beneficiaries with cardiovascular disease.
    Methods: The investigators chose 4 cardiovascular conditions that frequently require high-cost guideline-recommended drugs: severe hypercholesterolemia; heart failure with reduced ejection fraction (HFrEF); HFrEF with atrial fibrillation (AF); and cardiac transthyretin amyloidosis. This study included 4,137 Part D plans nationwide and compared projected annual out-of-pocket drug costs for each condition in 2022 (baseline), 2023 (rollout), 2024 (5% catastrophic coinsurance eliminated), and 2025 ($2,000 cap on out-of-pocket costs).
    Results: In 2022, mean projected annual out-of-pocket costs were $1,629 for severe hypercholesterolemia, $2,758 for HFrEF, $3,259 for HFrEF with AF, and $14,978 for amyloidosis. In 2023, the initial IRA rollout will not significantly change out-of-pocket costs for the 4 conditions. In 2024, elimination of 5% catastrophic coinsurance will lower out-of-pocket costs for the 2 costliest conditions: HFrEF with AF ($2,855, 12% reduction) and amyloidosis ($3,468, 77% reduction). By 2025, the $2,000 cap will lower out-of-pocket costs for all 4 conditions to $1,491 for hypercholesterolemia (8% reduction), $1,954 for HFrEF (29% reduction), $2,000 for HFrEF with AF (39% reduction), and $2,000 for cardiac transthyretin amyloidosis (87% reduction).
    Conclusions: The IRA will reduce Medicare beneficiaries' out-of-pocket drug costs for the selected cardiovascular conditions by 8% to 87%. Future studies should assess the IRA's impact on adherence to guideline-directed cardiovascular therapies and health outcomes.
    MeSH term(s) United States/epidemiology ; Humans ; Aged ; Cardiovascular Diseases/drug therapy ; Health Expenditures ; Heart Failure/drug therapy ; Hypercholesterolemia ; Drug Costs ; Medicare ; Stroke Volume ; Amyloid Neuropathies, Familial ; Atrial Fibrillation
    Language English
    Publishing date 2023-05-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2023.03.414
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.

    DeJong, Colette / Wachter, Robert M

    JAMA internal medicine

    2020  Volume 180, Issue 8, Page(s) 1118–1119

    MeSH term(s) Betacoronavirus ; Coronavirus Infections/drug therapy ; Humans ; Hydroxychloroquine ; Internet ; Pandemics ; Pneumonia, Viral ; United States
    Chemical Substances Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language English
    Publishing date 2020-04-29
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2020.1853
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Deferral of Care for Serious Non-COVID-19 Conditions: A Hidden Harm of COVID-19.

    DeJong, Colette / Katz, Mitchell H / Covinsky, Kenneth

    JAMA internal medicine

    2020  Volume 181, Issue 2, Page(s) 274

    MeSH term(s) Acute Disease ; COVID-19 ; Chronic Disease ; Hospitalization ; Humans ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-10-19
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2020.4016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Addressing Mistreatment in Medical Education.

    Thakkar, Anjali B / Dejong, Colette / Katz, Mitchell H

    JAMA internal medicine

    2020  Volume 180, Issue 5, Page(s) 665

    MeSH term(s) Education, Medical ; Education, Medical, Undergraduate ; Ethnic Groups ; Female ; Humans ; Male ; Prevalence ; Sexual Behavior ; Students, Medical
    Language English
    Publishing date 2020-03-02
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2020.0004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Tenofovir-based PrEP for COVID-19: an untapped opportunity?

    DeJong, Colette / Spinelli, Matthew A / Okochi, Hideaki / Gandhi, Monica

    AIDS (London, England)

    2021  Volume 35, Issue 9, Page(s) 1509–1511

    MeSH term(s) Anti-HIV Agents/therapeutic use ; COVID-19 ; Emtricitabine ; HIV Infections/drug therapy ; Humans ; Medication Adherence ; Pre-Exposure Prophylaxis ; SARS-CoV-2 ; Tenofovir
    Chemical Substances Anti-HIV Agents ; Tenofovir (99YXE507IL) ; Emtricitabine (G70B4ETF4S)
    Language English
    Publishing date 2021-02-23
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 639076-6
    ISSN 1473-5571 ; 0269-9370 ; 1350-2840
    ISSN (online) 1473-5571
    ISSN 0269-9370 ; 1350-2840
    DOI 10.1097/QAD.0000000000002877
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life Saving.

    DeJong, Colette / Grant, Richard W

    JAMA internal medicine

    2020  Volume 180, Issue 5, Page(s) 727

    MeSH term(s) Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Disease Progression ; Glomerular Filtration Rate ; Humans ; Kidney ; Renin-Angiotensin System
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors
    Language English
    Publishing date 2020-03-09
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2020.0300
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top